Skip to main content
. 2024 Jul 29;16(12):779–790. doi: 10.1080/1750743X.2024.2368342

Figure 4.

Figure 4.

GATHER2 efficacy outcomes for ACP 2-mg cohort compared with sham through 12 months. A MMRM was used to assess differences between the treatment groups in the rate of growth of the observed GA area (slope) over 12 months.